mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for ZNF473
Gene summary
Basic gene Info.Gene symbolZNF473
Gene namezinc finger protein 473
SynonymsHZFP100|ZN473
CytomapUCSC genome browser: 19q13.33
Type of geneprotein-coding
RefGenesNM_001006656.1,
NM_015428.1,
Descriptionzfp-100zinc finger protein 100 homologzinc finger protein ZFP100
Modification date20141207
dbXrefs HGNC : HGNC
Ensembl : ENSG00000142528
HPRD : 11721
Vega : OTTHUMG00000183054
ProteinUniProt: Q8WTR7
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_ZNF473
BioGPS: 25888
PathwayNCI Pathway Interaction Database: ZNF473
KEGG: ZNF473
REACTOME: ZNF473
Pathway Commons: ZNF473
ContextiHOP: ZNF473
ligand binding site mutation search in PubMed: ZNF473
UCL Cancer Institute: ZNF473
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006398histone mRNA 3'-end processing16714279


Top
Ligand binding site mutations for ZNF473

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
H580Q579EBLCA1
C349Y347HCOAD1
H609R611ICOAD1
H836H836NCOAD1
C651E650KCOAD1
H286H286DHNSC1
H286T287SLUSC1
H836,H832R834GLUSC1
C651G652RSTAD1
H609R611KSTAD1
H609R611KUCEC1
C679D680NUCEC1
H668A669TUCEC1
H453,H449R451QUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for ZNF473
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
H836R834G-1.5921508
H832R834G-1.5921508
H609R611K-1.2266053
H449R451Q-1.1811866
H453R451Q-1.1811866
H286H286D-1.0702882
C349Y347H-1.0700334
C651E650K-1.0312796
C679D680N-0.89965127
H609R611I-0.77552983
H836H836N-0.70151879
C651G652R-0.62843072
H580Q579E-0.58897354
H286T287S-0.5426255
H668A669T-0.53201234
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for ZNF473 from PDB

Top
Differential gene expression and gene-gene network for ZNF473
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of ZNF473 and the right PPI network was created from samples without mutations in the LBS of ZNF473. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for ZNF473
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for ZNF473
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of ZNF473 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of ZNF473
Multiple alignments for Q8WTR7 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas